Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar
Crossmark

Evaluation of the Anxiolytic Effect of Vitex agnus-castus on Female Mice and Possible Role of Estrogen Receptors

Ardeshir Arzi 1 , 2 , Hoda Mojiri-Forushani 3 , * and Neda Sistani Karampour 1 , 2
Authors Information
1 Department of Pharmacology and Toxicology, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Physiology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 Abadan School of Medical Sciences, Abadan, Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: 14 (2); e63570
  • Published Online: May 11, 2019
  • Article Type: Research Article
  • Received: November 1, 2016
  • Revised: November 2, 2017
  • Accepted: April 22, 2018
  • DOI: 10.5812/jjnpp.63570

To Cite: Arzi A, Mojiri-Forushani H, Sistani Karampour N. Evaluation of the Anxiolytic Effect of Vitex agnus-castus on Female Mice and Possible Role of Estrogen Receptors, Jundishapur J Nat Pharm Prod. Online ahead of Print ; 14(2):e63570. doi: 10.5812/jjnpp.63570.

Abstract
Copyright © 2019, Jundishapur Journal of Natural Pharmaceutical Products. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Somers JM, Goldner EM, Waraich P, Hsu L. Prevalence and incidence studies of anxiety disorders: A systematic review of the literature. Can J Psychiatry. 2006;51(2):100-13. doi: 10.1177/070674370605100206. [PubMed: 16989109].
  • 2. Dang H, Sun L, Liu X, Peng B, Wang Q, Jia W, et al. Preventive action of Kai Xin San aqueous extract on depressive-like symptoms and cognition deficit induced by chronic mild stress. Exp Biol Med (Maywood). 2009;234(7):785-93. doi: 10.3181/0812-RM-354. [PubMed: 19429857].
  • 3. Onasanwo SA, Chatterjee M, Palit G. Antidepressant and anxiolytic potentials of dichloromethane fraction from Hedranthera barteri. Afr J Biomed Res. 2010;13(1):76-81.
  • 4. Sandford JJ, Argyropoulos SV, Nutt DJ. The psychobiology of anxiolytic drugs. Part 1: Basic neurobiology. Pharmacol Ther. 2000;88(3):197-212. doi: 10.1016/S0163-7258(00)00082-6. [PubMed: 11337025].
  • 5. Beracochea D. Anterograde and retrograde effects of benzodiazepines on memory. ScientificWorldJournal. 2006;6:1460-5. doi: 10.1100/tsw.2006.243. [PubMed: 17115086]. [PubMed Central: PMC5917174].
  • 6. Lader M, Tylee A, Donoghue J. Withdrawing benzodiazepines in primary care. CNS Drugs. 2009;23(1):19-34. doi: 10.2165/0023210-200923010-00002. [PubMed: 19062773].
  • 7. Galdino PM, Nascimento MV, Sampaio BL, Ferreira RN, Paula JR, Costa EA. Antidepressant-like effect of Lafoensia pacari A. St.-Hil. ethanolic extract and fractions in mice. J Ethnopharmacol. 2009;124(3):581-5. doi: 10.1016/j.jep.2009.05.001. [PubMed: 19439172].
  • 8. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998;139(10):4252-63. doi: 10.1210/endo.139.10.6216. [PubMed: 9751507].
  • 9. Lund TD, Lephart ED. Dietary soy phytoestrogens produce anxiolytic effects in the elevated plus-maze. Brain Res. 2001;913(2):180-4. doi: 10.1016/S0006-8993(01)02793-7. [PubMed: 11549384].
  • 10. Lephart ED, Setchell KD, Handa RJ, Lund TD. Behavioral effects of endocrine-disrupting substances: Phytoestrogens. ILAR J. 2004;45(4):443-54. doi: 10.1093/ilar.45.4.443. [PubMed: 15454683].
  • 11. Mills S, Bone K. Principles and practice of phytotherapy. Modern herbal medicine. Edinburgh: Churchill Livingstone; 2000.
  • 12. Hankey A. CAM and the phenomenology of pain. Evid Based Complement Alternat Med. 2006;3(1):139-41. doi: 10.1093/ecam/nek002. [PubMed: 16550235]. [PubMed Central: PMC1375225].
  • 13. Jarry H, Spengler B, Porzel A, Schmidt J, Wuttke W, Christoffel V. Evidence for estrogen receptor beta-selective activity of Vitex agnus-castus and isolated flavones. Planta Med. 2003;69(10):945-7. doi: 10.1055/s-2003-45105. [PubMed: 14648399].
  • 14. Chopin Lucks B. Vitex agnus castus essential oil and menopausal balance: A research update [complementary therapies in nursing and midwifery 8 (2003) 148-154]. Complement Ther Nurs Midwifery. 2003;9(3):157-60. doi: 10.1016/S1353-6117(03)00020-9. [PubMed: 12852933].
  • 15. Bergmann J, Luft B, Boehmann S, Runnebaum B, Gerhard I. [The efficacy of the complex medication Phyto-Hypophyson L in female, hormone-related sterility. A randomized, placebo-controlled clinical double-blind study]. Forsch Komplementarmed Klass Naturheilkd. 2000;7(4):190-9. German. doi: 10.1159/000021343. [PubMed: 11025394].
  • 16. Adams JD Jr, Garcia C. Women's health among the Chumash. Evid Based Complement Alternat Med. 2006;3(1):125-31. doi: 10.1093/ecam/nek021. [PubMed: 16550233]. [PubMed Central: PMC1375244].
  • 17. Yaghmaei P, Oryan S, Fatehi Gharehlar L, Salari AA, Solati J. Possible modulation of the anexiogenic effects of vitex agnus-castus by the serotonergic system. Iran J Basic Med Sci. 2012;15(2):768-76. [PubMed: 23493923]. [PubMed Central: PMC3586884].
  • 18. Zarrindast MR, Babapoor-Farrokhran S, Babapoor-Farrokhran S, Rezayof A. Involvement of opioidergic system of the ventral hippocampus, the nucleus accumbens or the central amygdala in anxiety-related behavior. Life Sci. 2008;82(23-24):1175-81. doi: 10.1016/j.lfs.2008.03.020. [PubMed: 18456284].
  • 19. Liu J, Burdette JE, Xu H, Gu C, van Breemen RB, Bhat KP, et al. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem. 2001;49(5):2472-9. doi: 10.1021/jf0014157. [PubMed: 11368622].
  • 20. Genazzani AR, Petraglia F, Mercuri N, Brilli G, Genazzani AD, Bergamaschi M, et al. Effect of steroid hormones and antihormones on hypothalamic beta-endorphin concentrations in intact and castrated female rats. J Endocrinol Invest. 1990;13(2):91-6. doi: 10.1007/BF03349515. [PubMed: 2139451].
  • 21. Jacobs PA, Hyland ME. An evaluation of the benefits of taking hormone replacement therapy with other prescription drugs. Maturitas. 2003;46(4):273-81. doi: 10.1016/S0378-5122(03)00198-1. [PubMed: 14625124].
  • 22. Blasi C. Influence of benzodiazepines on body weight and food intake in obese and lean Zucker rats. Prog Neuropsychopharmacol Biol Psychiatry. 2000;24(4):561-77. doi: 10.1016/S0278-5846(00)00093-2. [PubMed: 10958151].
  • 23. Lucion AB, Charchat H, Pereira GA, Rasia-Filho AA. Influence of early postnatal gonadal hormones on anxiety in adult male rats. Physiol Behav. 1996;60(6):1419-23. doi: 10.1016/S0031-9384(96)00246-6. [PubMed: 8946485].
  • 24. Mora S, Dussaubat N, Diaz-Veliz G. Effects of the estrous cycle and ovarian hormones on behavioral indices of anxiety in female rats. Psychoneuroendocrinology. 1996;21(7):609-20. doi: 10.1016/S0306-4530(96)00015-7. [PubMed: 9044444].
  • 25. File SE, Pellow S. The effects of PK 11195, a ligand for benzodiazepine binding sites, in animal tests of anxiety and stress. Pharmacol Biochem Behav. 1985;23(5):737-41. doi: 10.1016/0091-3057(85)90064-4. [PubMed: 3001779].
  • 26. Pellow S, File SE. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat. Pharmacol Biochem Behav. 1986;24(3):525-9. doi: 10.1016/0091-3057(86)90552-6. [PubMed: 2871560].
  • 27. Weiss SM, Wadsworth G, Fletcher A, Dourish CT. Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety. Neurosci Biobehav Rev. 1998;23(2):265-71. doi: 10.1016/S0149-7634(98)00027-X. [PubMed: 9884119].
  • 28. Etgen AM, Shamamian P. Regulation of estrogen-stimulated lordosis behavior and hypothalamic progestin receptor induction by antiestrogens in female rats. Horm Behav. 1986;20(2):166-80. doi: 10.1016/0018-506X(86)90015-2. [PubMed: 3522395].
  • 29. Loch EG, Selle H, Boblitz N. Treatment of premenstrual syndrome with a phytopharmaceutical formulation containing Vitex agnus castus. J Womens Health Gend Based Med. 2000;9(3):315-20. doi: 10.1089/152460900318515. [PubMed: 10787228].
  • 30. Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: Prospective, randomised, placebo controlled study. BMJ. 2001;322(7279):134-7. doi: 10.1136/bmj.322.7279.134. [PubMed: 11159568]. [PubMed Central: PMC26589].
  • 31. Newall CA, Anderson LA, Phillipson JD. Herbal medicines. A guide for health-care professionals. London: The Pharmaceutical Press; 1996.
  • 32. Schulz V, Hänsel R, Tyler VE. Fitoterapia razionale: Scienza e piante medicinali. Italy: Libreria Scientifica Ghedimedia; 2003.
  • 33. Russo R, Corosu R. The clinical use of a preparation based on phyto-oestrogens in the treatment of menopausal disorders. Acta Biomed. 2003;74(3):137-43. [PubMed: 15055018].
  • 34. Pourabbas S, Kesmati M, Rasekh A. Study of the the anxiolytic effects of fennel and possible roles of both gabaergic system and estrogen receptors in these effects in adult female rat. Physiol Pharmacol. 2011;15(1):134-43.
  • 35. Lund TD, Rovis T, Chung WC, Handa RJ. Novel actions of estrogen receptor-beta on anxiety-related behaviors. Endocrinology. 2005;146(2):797-807. doi: 10.1210/en.2004-1158. [PubMed: 15514081].
  • 36. Krezel W, Dupont S, Krust A, Chambon P, Chapman PF. Increased anxiety and synaptic plasticity in estrogen receptor beta -deficient mice. Proc Natl Acad Sci U S A. 2001;98(21):12278-82. doi: 10.1073/pnas.221451898. [PubMed: 11593044]. [PubMed Central: PMC59805].
  • 37. McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocr Rev. 1999;20(3):279-307. doi: 10.1210/edrv.20.3.0365. [PubMed: 10368772].
  • 38. Couse JF, Korach KS. Estrogen receptor null mice: What have we learned and where will they lead us? Endocr Rev. 1999;20(3):358-417. doi: 10.1210/edrv.20.3.0370. [PubMed: 10368776].
  • 39. Lephart ED, West TW, Weber KS, Rhees RW, Setchell KD, Adlercreutz H, et al. Neurobehavioral effects of dietary soy phytoestrogens. Neurotoxicol Teratol. 2002;24(1):5-16. doi: 10.1016/S0892-0362(01)00197-0. [PubMed: 11836067].
  • 40. Almstrup K, Fernandez MF, Petersen JH, Olea N, Skakkebaek NE, Leffers H. Dual effects of phytoestrogens result in u-shaped dose-response curves. Environ Health Perspect. 2002;110(8):743-8. doi: 10.1289/ehp.02110743. [PubMed: 12153753]. [PubMed Central: PMC1240943].
  • 41. Walf AA, Frye CA. ERbeta-selective estrogen receptor modulators produce antianxiety behavior when administered systemically to ovariectomized rats. Neuropsychopharmacology. 2005;30(9):1598-609. doi: 10.1038/sj.npp.1300713. [PubMed: 15798780].
  • 42. Poluzzi E, Piccinni C, Raschi E, Rampa A, Recanatini M, De Ponti F. Phytoestrogens in postmenopause: The state of the art from a chemical, pharmacological and regulatory perspective. Curr Med Chem. 2014;21(4):417-36. doi: 10.2174/09298673113206660297. [PubMed: 24164197]. [PubMed Central: PMC3963458].
  • 43. Martinez J, Lewi JE. An unusual case of gynecomastia associated with soy product consumption. Endocr Pract. 2008;14(4):415-8. doi: 10.4158/EP.14.4.415. [PubMed: 18558591].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments